Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT.
about
Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Long-term outcome of Epstein-B ...... mab following allogeneic HSCT.
@en
type
label
Long-term outcome of Epstein-B ...... mab following allogeneic HSCT.
@en
prefLabel
Long-term outcome of Epstein-B ...... mab following allogeneic HSCT.
@en
P2093
P2860
P1433
P1476
Long-term outcome of Epstein-B ...... imab following allogeneic HSCT
@en
P2093
Helene Hallböök
Johan Arvidson
Kalle Sällström
Karlis Pauksens
P2860
P304
P356
10.1080/10428194.2017.1365860
P577
2017-08-23T00:00:00Z